The number one cause of bile duct cancer worldwide is chronic infection with liver flukes, tiny parasitic worms found in the fresh waters of Southeast Asia. These parasites settle inside the bile ducts after a person eats raw or undercooked freshwater fish, and the decades of irritation they cause can eventually trigger cancerous changes. In Western countries, where liver fluke infection is rare, the leading risk factor is a chronic inflammatory condition called primary sclerosing cholangitis (PSC), which scars and narrows the bile ducts over time.
How Liver Flukes Cause Cancer
Two species of liver fluke are responsible for most parasite-driven bile duct cancers. One, found in Thailand, Laos, Vietnam, and Cambodia, is the Southeast Asian liver fluke. The other is the Chinese liver fluke, common in rural areas of Korea and China. Both follow the same path: a person eats contaminated fish, the larvae travel to the bile ducts, and the worms grow to adulthood inside those narrow channels.
Once lodged in the bile ducts, the flukes feed by attaching to and grazing on the duct lining. This creates repeated cycles of tissue damage and healing that can persist for years or even decades. The parasites also release growth factors, digestive enzymes, and tiny packages of biological material called extracellular vesicles. These secretions push bile duct cells to multiply faster than normal. Combined with the chronic inflammation and scarring at the attachment sites, this abnormal cell growth can eventually become cancerous. One growth factor released by the fluke is particularly potent at driving cell multiplication and promoting the shift from normal tissue to malignant tissue.
In regions where raw fish dishes are a dietary staple, bile duct cancer rates are dramatically higher than anywhere else in the world. Northeast Thailand has some of the highest incidence on the planet, directly linked to widespread liver fluke infection in the population.
Primary Sclerosing Cholangitis: The Top Western Risk Factor
For people in the United States, Europe, and other Western countries, primary sclerosing cholangitis (PSC) is the most significant risk factor. PSC is a progressive disease in which the bile ducts become inflamed and scarred for reasons that aren’t fully understood, though it’s closely linked to chronic ulcerative colitis, an inflammatory bowel condition.
The lifetime risk of developing bile duct cancer for someone with PSC is substantial. Studies report an overall risk ranging from 8% to 36%, with a 10-year cumulative incidence between 9% and 31%. Much of the risk is concentrated in the first decade after diagnosis, and it doesn’t appear to climb much further after that. People with PSC are typically monitored with regular imaging and blood tests. One blood marker, CA 19-9, detects bile duct cancer in PSC patients with about 89% sensitivity and 86% specificity when levels exceed a certain threshold, making it a useful (though imperfect) screening tool.
Other Conditions That Raise Risk
Several other conditions create the same basic environment of chronic inflammation and bile duct damage that drives cancer development.
- Bile duct cysts: These are abnormal sac-like dilations in the bile ducts, often present from birth. They block bile flow, causing ongoing inflammation and infection. In one study of 214 patients with these cysts, 7% developed biliary tract cancers, with two-thirds of those cancers arising in the common bile duct. Risk increases with age, particularly for those whose symptoms first appear after age 60. Surgical removal of the cysts once they’re diagnosed is the standard approach because the risk of cancer grows the longer the cysts remain.
- Fatty liver disease: A large South Korean study found that non-alcoholic fatty liver disease raised the risk of bile duct cancer by about 33%. When fatty liver disease occurred alongside diabetes, the risk jumped by 47% compared to people with neither condition.
- Hepatitis B and C: Chronic viral hepatitis creates long-term liver inflammation that can affect the bile ducts within the liver. These infections are more strongly tied to intrahepatic bile duct cancer (the type that starts inside the liver) than to cancers in the ducts outside it.
- Lynch syndrome: This inherited condition, caused by mutations in genes responsible for repairing DNA damage, increases the risk of many cancers, including bile duct and gallbladder cancers. It accounts for a small but meaningful fraction of cases.
Why Bile Duct Cancer Is Hard to Catch Early
Bile duct cancer, also called cholangiocarcinoma, is notoriously difficult to detect before it spreads. The bile ducts are deep inside the body, and early tumors rarely produce symptoms. When symptoms do appear, they typically include jaundice (yellowing of the skin and eyes), unexplained weight loss, and abdominal pain, but by that point the cancer has often advanced.
The survival statistics reflect this challenge. For intrahepatic bile duct cancers caught while still localized, the five-year survival rate is 25%. Once the cancer has spread to nearby lymph nodes, that drops to 12%, and for distant spread it falls to just 3%. Extrahepatic bile duct cancers follow a similar pattern: 19% for localized, 20% for regional, and 2% for distant disease. These numbers are based on patients diagnosed between 2015 and 2021.
The Common Thread: Chronic Inflammation
Whether the trigger is a parasitic worm, an autoimmune condition like PSC, a structural problem like bile duct cysts, or metabolic stress from fatty liver disease, the underlying mechanism is remarkably consistent. Prolonged inflammation damages the cells lining the bile ducts. The body repairs that damage by generating new cells, but each cycle of injury and repair carries a small chance of producing a genetic error. Over years or decades, those errors accumulate. Eventually, a cell acquires enough mutations to grow without restraint.
This is why age is a factor across nearly every risk category, and why conditions that persist for the longest time carry the greatest danger. For liver fluke infections, the cancer often doesn’t appear until decades after the initial exposure. For PSC, the risk is highest in the years following diagnosis when cumulative duct damage reaches a critical point. The practical takeaway is straightforward: any condition that causes ongoing irritation to the bile ducts deserves consistent monitoring, because catching changes early is the single biggest factor in improving outcomes.